CoChat

Chronic blockade of cannabinoid CB2receptors induces anxiolytic‐like actions associated with alterations in GABAAreceptors

Open access
García‐Gutiérrez, María S, García‐Bueno, Borja, Zoppi, Silvia, Leza, Juan C, Manzanares, Jorge · 2012 · British Journal of Pharmacology
Cited by 134

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

BACKGROUND AND PURPOSE The aim of this study was to explore the effects of CB 2 receptor agonist and antagonist in the regulation of anxiety‐like behaviours. EXPERIMENTAL APPROACHES Effects of acute and chronic treatment with the CB 2 receptor agonist JWH133 and CB 2 receptor antagonist AM630 were evaluated in the light‐dark box (LDB) and elevated plus maze (EPM) tests in Swiss ICR mice. CB 2 receptor, GABA A α 2 and GABA A γ 2 gene and protein expression in the cortex and amygdala of mice chronically treated with JWH133 or AM630 were examined by RT‐PCR and Western blot. Effects of chronic AM630 treatment were evaluated in spontaneously anxious DBA/2 mice in LDB. KEY RESULTS Acute JWH133 treatment failed to produce any effect. Acute AM630 treatment increased anxiety and was blocked by pre‐treatment with JWH133. Chronic JWH133 treatment increased anxiety‐like behaviour whereas chronic AM630 treatment was anxiolytic in LDB and EPM tests. Chronic AM630 treatment increased gene and reduced protein expression of CB 2 receptors, GABA A α 2 and GABA A γ 2 in cortex and amygdala. Chronic JWH133 treatment resulted in opposite gene and protein alterations. In addition, chronic AM630 administration decreased the anxiety of DBA/2 mice in the LDB test. CONCLUSIONS AND IMPLICATIONS The opposing behavioural and molecular changes observed after chronic treatment with AM630 or JWH133 support the key role of CB 2 receptors in the regulation of anxiety. Indeed, the efficacy of AM630 in reducing the anxiety of the spontaneously anxious DBA/2 strain of mice strengthens the potential of the CB 2 receptor as a new target in the treatment of anxiety‐related disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2011.01625.x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 134

Metadata

Authors
García‐Gutiérrez, M. S., García‐Bueno, B., Zoppi, S., Leza, J. C., & Manzanares, J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2012-01-25
Volume
165
Issue
4
Pages
951-964
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1512507748
Cited by
134
References
15
FWCI
5.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic blockade of cannabinoid CB2receptors induces anxiolytic‐like actions associated with alterations in GABAAreceptors. https://app.cochat.ai/papers/10.1111/j.1476-5381.2011.01625.x
The paper
García‐Gutiérrez, M. S., García‐Bueno, B., Zoppi, S., Leza, J. C., & Manzanares, J. (2012). Chronic blockade of cannabinoid CB2receptors induces anxiolytic‐like actions associated with alterations in GABAAreceptors. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2011.01625.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.